請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/34903
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 林?輝 | |
dc.contributor.author | Yi-Chau Huang | en |
dc.contributor.author | 黃怡超 | zh_TW |
dc.date.accessioned | 2021-06-13T06:36:32Z | - |
dc.date.available | 2008-01-06 | |
dc.date.copyright | 2006-01-06 | |
dc.date.issued | 2005 | |
dc.date.submitted | 2005-12-13 | |
dc.identifier.citation | [1] Yamada Y, Ueda M, Naiki T, Takahashi M, Hata K-I, Nagasaka T. Autogenous injectable bone for regeneration with mesenchymal stem cells and platelet-rich plasma: tissue-engineered bone regeneration. Tissue Eng. 2004;10:955-964.
[2] Sheridan RL, Hegarty M, Tompkins RG, Burke JF. Artificial skin in massive burns-results to 10 years. Eur. J. Plastic Surg. 1994;17:91-93. [3] Lofgren H, Johannsson V, Olsson T, Ryd L, Levander B. Rigid fusion after cloward operation for cervical disc disease using autograft, allograft, or xenograft: a randomized study with radiostereometric and clinical follow-up assessment. Spine. 2000;25:15:1908-1916. [4] Brigham PA, McLoughlin E. Burn incidence and medical care use in the United States: estimates, trends, and data sources. J. Burn Care Rehabil. 1996;17:95-107. [5] 行政院主計處:國情統計通報:火災事故減少,惟人為縱火案增加。行政院主計處網站。摘自:http://www.dgbas.gov.tw/dgbas03/bs3/report/N900302.html, 2001。 [6] 慈濟醫學 2002;14:163-172 [7] De-Souza D, Green L. Pharmacological nutrition after burn injury. J. Nutr. 1998;128:797-801. [8] Koji K, Vacanti CA. Generation of a tissue-engineered tracheal equivalent. Biotechnol. Appl. Biochem. 2004;39:257–262. [9] Petruzzelli GJ, Johnson JT. Skin grafts. Otolaryngol Clin North Am. 1994;27:1: 25-37. [10] Gallico GG 3rd. Biologic skin substitutes. Clin. Plast. Surg. 1990;17:3: 519-526. [11] Sabolinski ML, Alvarez O, Auletta M, Mulder G, Parenteau NL. Cultured skin as a smart material for healing wounds: experience in venous ulcers. Biomaterials. 1996; 17:3:311. [12] Presland RB, Dale BA. Epithelial structural proteins of the skin and oral cavity: function in health and disease. Crit. Rev. Oral Biol. Med. 2000;11:383-408. [13] Luis Carlos Junqueira, Jose Carneiro. Basic Histology: Text & Atlas, 10th Edition. 2002. McGraw-Hill Medical [14] LeBoit, Philip E. Trichoblastoma, basal cell carcinoma, follicular differentiation: What should we trust? Am. J. Dermatopathol. 2003;25:3:260-263. [15] Gray, Mikel. Preventing, managing perineal dermatitis: A shared goal for wound and continence care. J. Wound Ostomy Continence Nurs. 2004;31:1:S2-S12 [16] Eichenfield, Lawrence F, Hardaway, Christina A. Neonatal dermatology. Current Opinion in Pediatrics. 1999;11:5:471. [17] Sadler M, Strain JJ, Caballero B. Encyclopedia of Human Nutrition. 1999 Academic Press. [18] Beers MH, Berkov R. The Merck Manual of Diagnosis and Therapy. 17th edition. 1999. Merck Research Laboratories [19] Ahmad S. Treatment of post-burn bacterial infections by bacteriophages, specifically ubiquitous pseudomonas spp. notoriously resistant to antibiotics. Med. Hypotheses. 2002; 58:4: 327-331. [20] Ryan CM, Schoenfeld DA, Thorpe WP. Risk of death following burn injury. N. Engl. J. Med. 1998;338:6:362-366. [21] Martin P. Wound healing - aiming for perfect skin regeneration. Science. 1997; 276:75-81. [22] Witte MB, Barbul A. General principles of wound healing. Surg. Clin. North America. 1997; 77:509-528. [23] Clark RAF. The Molecular and Cellular Biology of Wound Repair. 2nd edition. 1996. Plenum Press. [24] Kirsner RS, Eaglstein WH. The wound healing process. Dermatol Clin. 1993;11:4:629-640. [25] Robin Reid, Fiona Roberts. Pathology Illustrated. 6th Edition. 2005. Hardcover. [26] Stadelmann WK, Digenis AG, Tobin GR. Impediments to wound healing. Am. J. Surg. 1998;176:39S-47S. [27] Skala R, Fox CF, Fung B. Preface. Tissue Eng. 1988;1. [28] Rui LR, Julio SR. Biodegradable Systems in Tissue Engineering and Regenerative Medicine. 2004. CRC Press. [29] Lanza RP, Langer R, Vacanti J, Principles of Tissue Engineering. 2nd edition. 2001, Hardcover. [30] Selcuk I, Ergin E, Yasemin S, Nejat IR. Prolongation of skin xenograft survival with modified cultured fibroblasts. Plast. Reconstr. Surg. 2003;111:1:283-285. [31] Auger FA, Berthod F, Moulin V, Pouliot R, Germain L. Tissue-engineered skin substitutes: from in vitro constructs to in vivo applications. Biotechnol Appl. Biochem. 2004;39:263-275. [32] Curran MP, Plosker GL. Bilayered bioengineered skin substitute (Apligraf): a review of its use in the treatment of venous leg ulcers and diabetic foot ulcers. BioDrugs. 2002;16:6:439-455. [33] J. T. Schulz III, ¬Tompkins RG, Burke JF. ¬Artificial skin. Annu. Rev. Med. 2000;51: 231-244. [34] Hansbrough JF, Franco ES. Skin replacements. Clin. Plast. Surg. 1998;3:407-423. [35] Krejci NC, McGuire J. Treatment of burns with skin substitutes. J. Dermatol Sci.1992;4:149-155. [36] Barret JP, Dziewalski P, Ramzy PI, Wolf SE, Desai MH, Herndon DN. Biobrane versus 196 silver sulfadiazine in second-degree pediatric burns. Plast. Reconstr. Surg. 2000;105:62-65. [37] Noordenbos J, Dore C, Hansbrough JF. Safety and efficacy of transcyte for the treatment of partialthickness burns. J. Burn Care Rehab. 1999;20:24581. [38] The Integra Artificial Skin Dermal Regeneration Template Physician Training Manual. 1996. Integra LifeScience Corporation. [39] Wainwright DJ. Use of an acellular allograft dermal matrix (alloderm) in the management of full-thickness burns. Burns. 1995;21:243-248. [40] Falanga V. Apligraf treatment of venous ulcers and other chronic wounds. J.Dermatol. 1998; 25:812-817. [41] Gentzkow GD, Iwasaki SD, Hershon KS, Mengel M, Prendergast JJ, Ricotta JJ, Steed DP, Lipkin S.Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care. 1996;19:350-354. [42] Ho WS. Skin substitutes: An overview annals of the college of surgeons of Hong Kong. 2002;6: 4:102-108. [43] Rheinwald JG, Green H. Serial cultivation of strains of human epidermal keratinocyte: The formation of keratinocyte colonies from single cells. Cell .1975; 6 :331-334. [44] Lopez Valle CA , Germain L , Rouabhia M, Xu W, Guignard R, Goulet F, Auger FA.Grafting on nude mice of living skin equivalent produced using human collagens. Transplantation. 1996;62:317-323. [45] Medalie DA, Eming SA, Tompkins RG, Yarmush ML, Krueger GG, Morgan JR. Evaluation of human skin reconstituted from composite grafts of cultured keratinocytes and human acellular dermis transplanted to athymic mice. J. Invest. Dermatol.1996;107:121-127. [46] Medalie DA, Eming SA, Collins ME, Tompkins, Ronald G, Yarmush, Martin L, Morgan, Jeffrey R.2. Difference in dermal analogs influence subsequent pigmentation, epidermal differentiation, basement membrane, and rete ridge formation of transplanted composite skin grafts 1. Transplantation. 1997;64:454-465. [47] Boyce ST, GoretskyMJ, Greenhalgh DG, Kagan RJ, Rieman MT, Warden GD. Comparative assessment of cultured skin substitutes and native skin autograft for treatment of full-thickness burns. Ann. Surg. 1995;222:6:743-752. [48] Murashita T, Nakayama Y, Hirano T, Ohashi S. Acceleration of granulation tissue ingrowth by hyaluronic acid in artificial skin. Br. J. Plast. Surg.1996;49:1:58-63. [49] Smola H , Stark HJ , Thiekotter G, Mirancea N, Krieg T, Fusenig NE. Dynamics of basement membrane formation by keratinocyte-fibroblast interactions in organotypic skin culture. Exp. Cell Res. 1998;239:2:399-410. [50] Boyce ST, Supp AP , Harriger MD, Greenhalgh DG, Warden GD. Topical nutrients promote engraftment and inhibit wound contraction of cultured skin substitutes in athymic mice. J. Invest. Dermatology. 1995;104:345-349. [51] Falanga V, Margolis D, Alvarez 0, Auletta M, Maggiacomo F, Altman M, Jensen J, Sabolinski M, Jan HY, the Human Skin Equivalent Investigators Group. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Arch. Dermatol. 1998;134:293-300. [52] Huston DP. The biology of the immune system. J. Am. Med. Assoc. 1997;278:1804-1814. [53] Fujita M, Furukawa F, Fujii K, Horiguchi Y, Takeichi M, Imamura S. Expression of cadherin cell adhesion molecules during human skin development: morphogenesis of epidermis, hair follicles and eccrine sweat ducts. Arch. Dermatol. Res. 1992;284:3:159-166. [54] Szepietowski J, Wasik F, Bielicka E, Nockowski P, Noworolska A. Soluble E-selectin serum levels correlate with disease activity in psoriatic patients. Clin. Exp. Dermatol. 1999;24:33-36. [55] Stefanescu M, Matache C, Onu A, Szegli G.. Modulation of cell adhesion by tyrosine kinases and phosphatases inhibitors. Roum. Arch. Microbiol. Immunol. 1997;56:3-15. [56] Gorski A. The role of cell adhesion molecules in immunopathology. Immunol. Today. 1994;15:251255. [57] Craig D. Wegner. Adhesion Molecules, Handbook of Immunopharmacology. 1994, Academic Press. Hardcover. [58] Chuong CM, Widelitz RB, Jiang TX. Adhesion molecules and homeoproteins in the phenotypic determination of skin appendages. J. Invest. Dermatol. 1993;101:1:10S-15S. [59] Dressler J, Bachmann L, Strejc P, Koch R, Muller E. Expression of adhesion molecules in skin wounds: diagnostic value in legal medicine. Forensic Sci. Int. 2000;113:173-176. [60] Wang Z, Symons JM, Goldstein SL, McDonald A, Miner JH, Kreidberg JA. (Alpha)3(beta)1 integrin regulates epithelial cytoskeletal organization. J. Cell Sci. 1999;112:Pt 17:2925-2935. [61] Juan S. Bonifacino, Mary Dasso, Jennifer Lippincott-Schwartz, Joe B. Harford, and Kenneth M. Yamada. Current Protocols in Cell Biology. 1999. John Wiley & Sons, Inc. [62] Djabourov M., Lechaire J.p., Gaill F., Structure and rheology of gelatin and collagen gels, Biorheology. 1993;30:191-205. [63] Park J.B. Bronzino J.D., Biomaterials: principles and applications. 2003, CRC Press. Hardcover. [64] Mitsuyama S, Tanaka S, Urushizaki F, Yoshida T, Ito A, Mori Y. Effects of glycosaminoglycan polysulfate on extracellular matrix metabolism in human skin cells. Res Commun Chem Pathol Pharmacol. 1994;83:2:179-193. [65] Humphrey, Tim, Brooks, Gavin, Cell Cycle Control Mechanisms and Protocols, 2004, HUMANA Press. Hardcover. [66] Cheryl D. Helgason and Cindy L. Miller. Stem Cell Books, Methods in Molecular Biology: Basic Cell Culture Protocols. 3rd Edition. 2004. Humana Press, Hardcover. [67] Amy Li, Normand P, Richard R and Pritinder K. Extensive tissue-regenerative capacity of neonatal human keratinocyte stem cells and their progeny. J. Clin. Invest. 2004;113:390-400. [68] Blanpain C, Lowry WE, Geoghegan A, Polak L, Fuchs E. Self-renewal, multipotency, and the existence of two cell populations within an epithelial stem cell niche. Cell. 2004;118:5:635-648. [69] Watt FM. Epidermal stem cells: Markers,patterning and the control of stem cell fate. Philos Trans R Soc Lond B Biol Sci.1998;353:1370::831-837. [70] Morris RJ, Potten CS. Slowly cycling(label retaining) epidermal cells behave like clonogenic stem cells in vitro. Cell Prolif.1994:27:5:279-289. [71] Akiyama M, Smith LT, Shimizu H. Changing patterns of localization of putative stem cells in developing human hair follicles. J. Invest. Dermatol. 2000;114:2:321-327. [72] Taylor G, Lehrer MS, Jensen PJ. Involvement of follicular stem cells in forming not only the follicle but also the epidermis. Cell. 2000;102:4:451-461. [73] Limat A, Mauri D, Hunziker T. Successful treatment of chronic leg ulcers with epidermal equivalents generated from cultured autologous outer root sheath cells. J. Invest. Dermatol.1996;107:1:128-135. [74] Jones PH. Epithelial stem cells. Bioessays.1997;19:8:683-690. [75] Levy L, Broad S, Diekmann D. Betal integrins regulate keratinocyte adhesion and differentiation by distinct mechanisms. Mol. biol Cell. 2000;11:2:453-466. [76] Michel M, Torok N, Godbout MJ. Keration 19 as a biochemical marker of skin stem cells in vivo and in vitro:keratin 19 expressing cells are differentially localized in function of anatomic sites,and their number varies with donor age and culture stage . J. Cell Sci. 1996;109:5:1017-1028. [77] Lyle S, Christofidou-Solomidou M, Liu Y, Elder DE, Albelda S, Cotsarelis G. The C8/144B monoclonal antibody recognizes cytokeratin-15 and defines the location of human hair follicale stem cells. J. Cell Sci.1998;111:21:3179-3188. [78] Dua HS, Shanmuganathan VA, Powell-Richards AO, Tighe PJ, Joseph A. Limbal epithelial crypts: a novel anatomical structure and a putative limbal stem cell niche. Br. J. Ophthalmol. 2005;89:529-532. [79] Pellegrini G, Dellambra E, Golisano O, Martinelli E, Fantozzi I, Bondanza S, Ponzin D, McKeon F, De Luca M. p63 identifies keratinocyte stem cells. Proc. Natl. Acad. Sci. USA. 2001;98:3156-3161. [80] Daniel A. Derivation of keratinocyte progenitor cells and skin formation from embryonic stem cells. Int. J. Dev. Biol. 2004;48:203-206. [81] Murphy GF, Flynn TC, Rice RH, Pinkus GS. Involucrin expression in normal and neoplastic human skin: a marker for keratinocyte differentiation. J. Invest. Dermatol. 1984;82:5:453-457. [82] Eckhart L, Declercq W, Ban J, Rendl M, Lengauer B, Mayer C, Lippens S, Vandenabeele P, Tschachler E. Terminal differentiation of human keratinocytes and stratum corneum formation is associated with caspase-14 activation. J. Invest. Dermatol. 2000;115:6:1148-1151. [83] Lippens S, Kockx M, Knaapen M, Mortier L, Polakowska R, Verheyen A, Garmyn M, Zwijsen A, Formstecher P, Huylebroeck D, Vandenabeele P, Declercq W. Epidermal differentiation does not involve the pro-apoptotic executioner caspases, but is associated with caspase-14 induction and processing. Cell Death and Differentiation. 2000;7:12:1218-1224. [84] Pistritto G, Jost M, Srinivasula SM, Baffa R, Poyet JL, Kari C, Lazebnik Y, Rodeck U, Alnemri ES. Expression and transcriptional regulation of caspase-14 in simple and complex epithelia. Cell Death and Differentiation. 2002 Sep;9:9:995-1006. [85] Rice RH, Green H. Presence in human epidermal cells of a soluble protein precursor of the cross-linked envelope: activation of the cross-linking by calcium ions. Cell. 1979;18:681–694. [86] Garach-Jehoshua O., Ravid A., Liberman UA., Reichrath J, Glaser T, Koren R. Upregulation of the calcium-dependent protease, calpain, during keratinocyte differentiation. Br. J. Dermatol. 1998;139:6:950-957. [87] Mayuzumi N, Ikeda S, Kawada H, Fan PS, Ogawa H. Effects of ultraviolet B irradiation, proinflammatory cytokines and raised extracellular calcium concentration on the expression of ATP2A2 and ATP2C1. Br. J. Dermatol. 2005;152:4:697. [88] Eckert RL, Rorke EA. Molecular biology of keratinocyte differentiation. Environ. Environ. Health Perspect. 1989;80:109–116. [89] Hiroko S, Taketo I, Hirohiko A, Hiroyuki O, Takeshi H. Effects of calcium concentration on the SOD activity and UVB-induced cytotoxicity in cultured human keratinocytes. Photodermatology, Photoimmunology & Photomedicine. 2005;21:1:9. [90]Younus J, Gilchrest, BA. Modulation of mRNA levels during human keratinocyte differentiation. J. Cell Physiol. 1992;152:232–239. [91] Banks EB, Crish JF, Welter F, Eckert RL. Characterization of human involucrin promoter distal regulatory region transcriptional activator elements – a role for Sp1 and AP1 binding sites. Biochem. J. 1998;331:61–68. [92] LaPres JJ, Hudson LG. Identification of a functional determinant of differentiation-dependent expression in the involucrin gene. J. Biol. Chem. 1996;271:23154–23160. [93] Hanley K, Ng DC, He SS, Lau P, Min K, Elias PM, Bikle DD, Mangelsdorf DJ, Williams ML, Feingold KR. Oxysterols induce differentiation in human keratinocytes and increase Ap-1-dependent involucrin transcription. J. Invest. Dermatol. 2000;114:545–553. [94] Chu M, Guo J, and Chen CY. Long-term Exposure to Nicotine, via Ras Pathway, Induces Cyclin D1 to Stimulate G1 Cell Cycle Transition. J. Biol. Chem. 2005;280:8:6369-6379. [95] Bancroft CC, Chen Z, Yeh J, Sunwoo JB, Yeh NT, Jackson S, Jackson C, Van Waes C. Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF- B and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines. Int. J. Cancer. 2002;99:4:538-548. [96] Juan AR, Stewart OS. Regulation of Plasma Membrane Ca2-ATPase by Small GTPases and Phosphoinositides in Human Platelets. J. Biol. Chem. 2000;275:26:19529-19535. [97] Teitelbaum I, Strasheim A, Berl T. Epidermal growth factor-stimulated phosphoinositide hydrolysis in cultured rat inner medullary collecting tubule cells. Regulation by G protein, calcium, and protein kinase C. J. Clin. Invest. 1990;85:4:1044–1050. [98] Superti-Furga G., Courtneidge S. Regulation of the Src protein tyrosine kinase. BioEssays. 1995;17:4:321-330. [99] Brown MT, Cooper JA. Regulation, substrates and functions of Src. Biochim. Biophys. Acta. 1996;1287:121–149. [100] Thomas SM, Brugge JS, Cellular functions regulated by Src family kinases. Annu. Rev. Cell Dev. Biol. 1997;13:513–609. [101] Schlessinger J. New roles for Src kinases in control of cell survival and angiogenesis. Cell. 2000;100:293–296. [102]. Vojtek AB, Ders CJ. Increasing Complexity of the Ras Signaling Pathway. J. Biol. Chem. 1998;273:19925-19928. [103] WERNER S, GROSE R. Regulation of Wound Healing by Growth Factors and Cytokines. Physiol. Rev. 2003; 83:3: 835-870. [104] Xiao JH, Feng X, Di W, Peng ZH, Li LA, Chambon P, Voorhees JJ. Identification of heparin-binding EGF-like growth factor as a target in intercellular regulation of epidermal basal cell growth by suprabasal retinoic acid receptors. EMBO J. 1999;18:6:1539-1548. [105] Yuji S, Rina K, Daisuke N, Ryo I, Sho T, Chie M, Koichi Y, Masanori N, Koji S, Eisuke M, Shigeki H, Koji H. Heparin-binding EGF-like growth factor accelerates keratinocyte migration and skin wound healing. J. Cell Sci.. 2005;118:2363-2370. [106] Mine N, Iwamoto R, Mekada E. HB-EGF promotes epithelial cell migration in eyelid development. Development. 2005;132:19:4317 - 4326. [107] Li DQ, Tseng SC. Differential regulation of keratinocyte growth factor and hepatocyte growth factor/scatter factor by different cytokines in human corneal and limbal fibroblasts. J. Cell Physiol. 1997;172:3:361-372. [108] Takashima H, Eguchi K, Kawakami A, Kawabe Y, Migita K, Sakai M, Origuchi T, Nagataki S. Cytokine production by endothelial cells infected with human T cell lymphotropic virus type I. Ann. Rheum. Dis.1996:55:632-637. [109] Mammaev SN, Lukina EA, Shul'pekova IuO, Levina AA, Ivashkin VT. Cytokine regulation of liver inflammation and fibrosis during chronic hepatic diseases. Klin. Lab. Diagn. 2001;12:37-40. [110] Teofoli P, Lotti T. Cytokines, fibrinolysis and vasculitis. Int. Angiol. 1995;14:2:125-129. [111] Ansel J, Perry P, Brown J, Damm D, Phan T, Hart C, Luger T, Hefeneider S. Cytokine modulation of keratinocyte cytokines. J. Invest. Dermatol. 1990;94:101-107. [112]. Benckert C, Jonas S, Cramer T, Marschall von Z, Schafer G, Peters M, Wagner K, Radke C, Wiedenmann B, Neuhaus P, Hocker M, Rosewicz S. Transforming Growth Factor {beta}1 Stimulates Vascular Endothelial Growth Factor Gene Transcription in Human Cholangiocellular Carcinoma Cells. Cancer Res. 2003;63:5: 1083-1092. [113] Go C, Li P, Wang XJ. Blocking Transforming Growth Factor {beta} Signaling in Transgenic Epidermis Accelerates Chemical Carcinogenesis: A Mechanism Associated with Increased Angiogenesis. Cancer Res. 1999;59:12:2861-2868. [114] Flanders KC, Burmester JK. Medical applications of transforming growth factor-{beta}. Clin. Med. Res. 2003;1:1:13-20. [115] Lee CH, Singla A, Lee Y. Biomedical applications of collagen, Int. J. Pharm. 2001:1-22. [116] Cheung DT, Perelman N, Ko EC, Nimni ME. Mechanism of crosslinking of proteins by glutaraldehyde. III: Reactions with collagen in tissues. Connective Tissue Research 1985;13:109-115. [117] Khor E. Methods for the treatment of collagenous tissue for bioprostheses. Biomaterials 1997;18:95-105. [118] Gelman RA., Poppke DC, Piez KA, Collagen fibril formation in vitro. The role of the nonhelical terminal regions, J. Biol. Chem. 1979;254:11741-11745. [119] Miller E.J., Rhodes R.K., Preparation and characterization of the different types of collagen . Methods Enzymol. 1982;82:59-62. [120] Gross J, Kirk D, The heat precipitation of collagen from neutral salt solutions: some rate-regulating factors. J. Biol. Chem. 1958;233:355-362. [121] Wood G.C, Keech MK, The function of fibrils form collagen solutions. Biochem. J. 1960;75:588-589. [122] Saltzman WM. Weaving cartilage at zero g: the reality of tissue engineering in space. Proc. Natl. Acad. Sci. 1997; 94:13380-13382. [123] Ham RG, McKeehan WL. Media and growth requirements. Methods Enzymol. 1979; 58:44-93. [124] Litwin J. A survey of various media and growth factors used in cell cultivation. Dev. Biol. Stand. 1979; 42:37-45. [125] Waymouth C, Ham RG, Chapple PJ. The Growth Requirements of Vertebrate Cells in Vitro. Edition 1981. Cambridge Univ. Press. [126] Morgan JF, Morton HJ, Parker RC. Nutrition of animal cells in tissue culture. I. Initial studies on a synthetic medium. Proc. Soc. Exp. Biol. Med. 1950;73:1-8. [127] Eagle, H. Amino acid metabolism in mammalian cell cultures. Science. 1959;130:432-437. [128] Dulbecco R, Freeman G. Plaque production by the polyoma virus. Virology. 1959;8:396-397. [129] Moore GE, Gerner RE, Franklin HA. Culture of normal human leucocytes. Jama. 1967;199:519-524. [130] Hutner SH. Inorganic nutrition. Ann. Rev. Microbiol. 1972;26:313-346. [131] Guilbert LJ, Iscove NN. Partial replacement of serum by selenite, transferrin, albumin and lecithin in haemopoietic cell cultures. Nature. 1976;263:594-595. [132] Waymouth C. The Growth Requirements of Vertebrate Cells in Vitro. 1981 Cambridge University Press [133] Mak VH, Cumpstone MB, Kennedy AH, Harmon CS, Guy RH, Potts RO. Barrier function of human keratinocyte cultures grown at the air-liquid interface. J. Invest. Dermatol. 1991;96:3:323-327. [134] Black AF, Bouez C, Perrier E, Schlotmann K, Chapuis F, Damour O. Optimization and characterization of an engineered human skin equivalent. Tissue Eng. 2005;11:723-733. [135] Margulis A, Zhang W, Garlick JA. In vitro fabrication of engineered human skin. Methods Mol. Biol. 2005;289:61-70. [136] Poumay Y, Dupont F, Marcoux S, Leclercq-Smekens M, Herin M, Coquette A. A simple reconstructed human epidermis: preparation of the culture model and utilization in in vitro studies. Arch. Dermatol. Res. 2004;296:5:203-11. [137] Masahiro KO, Natsuki O, Ryota U, Masahito T. Bioreactor design for successive culture of anchorage-dependent cells operated in an automated manner. Tissue Eng. 2005;11:535-545. [138] Kino-Oka M, Prenosil JE. Development of an on-line monitoring system of human keratinocyte growth by image analysis and its application to bioreactor culture. Biotechnol Bioeng. 2000;67:2:234-239. [139] Yamasaki K, Toriu N, Hanakawa Y, Shirakata Y, Sayama K, Takayanagi A, Ohtsubo M, Gamou S, Shimizu N, Fujii M, Miyazono K, Hashimoto K. Keratinocyte growth inhibition by high-dose epidermal growth factor is mediated by transforming growth factor beta autoinduction: a negative feedback mechanism for keratinocyte growth. J. Invest. Dermatol. 2003; 120:6:1030-1037. [140] Umbarger HE. Evidence for a negative-feedback mechanism in the biosynthesis of isoleucine. Science. 1956;123:848. [141] Bao S, Wang YJ, Patricia S, Alpana C, Andrea I. Doseff, Clay BM, Daren LK. Keratinocyte growth factor induces Akt kinase activity and inhibits Fas-mediated apoptosis in A549 lung epithelial cells. Am. J. Physiol. Lung. Cell. Mol. Physiol. 2005;288:L36-L42. [142] Breuhahn K, Mann A, MuÈller K, Wilhelmi A, Schirmacher P, Enk A, Blessing M. Overexpression of GM-CSF in the epidermis of transgenic mice induces both keratinocyte proliferation and apoptosis. Cell Growth Differ. 2000;11:111-121. [143] Valente AJ, Xie JF, Abramova MA, Wenzel UO, Abboud HE, Graves DT. A complex element regulates IFN-gamma-stimulated monocyte chemoattractantprotein-1 gene transcription. J. Immunol. 1998;161:3719-3728. [144] Gasperini S, Marchi M, Calzetti F. Gene expression and production of the monokine induced by IFN-gamma (MIG), IFN-inducible T cell alphachemoattractant (I-TAC), and IFN-gamma-inducible protein-10 (IP-10) chemokines by human neutrophils. J. Immunol. 1999;162:4928-4937. [145] Li Q, Normolle DP, Sayre DM. Immunological effects of BCG as an adjuvant in autologous tumor vaccines. Clin. Immunol. 2000;94:64-72. [146] Roop DR, Pamela HN,. Cheng CK, Yuspa SH. Keratin gene expression in mouse epidermis and cultured epidermal cells. Proc. Natl. Acad. Sci. USA 1983; 80:716-720. [147] Schweizer, J., M. Kinjo, G. Furstenberger,H. Winter. Sequential expression of mRNA-encoded keratin sets in neonatal mouse epidermis: basal cells with properties of terminally differentiating cells. Cell.1984;37:159-170. [148] el-Ghalbzouri A, Gibbs S, Lamme E, Van Blitterswijk CA, Ponec M. Effect of fibroblasts on epidermal regeneration. Br. J. Dermatol. 2002;147:230-243. [149] Maas-Szabowski N, Shimotoyodome A, Fusenig NE. Keratinocyte growth regulation in fibroblast cocultures via a double paracrine mechanism. J. Cell Sci. 1999;112:1843-1853. [150] Marchese C, Rubin J, Ron D, Faggioni A, Torrisi MR, Messina A, Frati L, Aaronson SA. Human keratinocyte growth factor activity on proliferation and differentiation of human keratinocytes: differentiation response distinguishes KGF from EGF family. J. Cell Physiol. 1990;144:326-332. [151] Karvinen S, Pasonen-Seppanen S, Hyttinen J, Pienimaki JP, Torronen K, Jokela TA, Tammi MI, Tammi R. Keratinocyte Growth Factor Stimulates Migration and Hyaluronan Synthesis in the Epidermis by Activation of Keratinocyte Hyaluronan Synthases 2 and 3. J. Biol. Chem. 2003;278:49:49495 - 49504. [152] Gillis P, Savla U, Volpert O, Jimenez B, Waters C, Panos R, Bouck. N. Keratinocyte growth factor induces angiogenesis and protects endothelial barrier function. J. Cell Sci. 1999;112:12:2049-2057. [153] Moon SE, Bhagavathula N, Varani J. Keratinocyte stimulation of matrix metalloproteinase-1 production and proliferation in fibroblasts: regulation through mitogen-activated protein kinase signalling events. Br. J. Cancer. 2002;457-464. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/34903 | - |
dc.description.abstract | 摘要
由於纖維母細胞能適時適量的提供生長因子幫助多種細胞增生,本研究的首要目標,即是以纖維母細胞促進表皮角質幹細胞增生。以含有纖維母細胞的供養膠體及其配方液的最佳化組合來培養皮角質幹細胞,使角質幹細胞增生,不易產生分化,為組織工程皮膚提供大量且高品質的角質幹細胞。 供養膠體的最佳細胞密度由其生產之KGF與GM-CSF濃度來做選擇,最佳之細胞密度為1x105 cells/gel。可以分泌足夠量的生長因子在想要收集的培養液中,收集的培養液可以進ㄧ步與新鮮培養液配製成配方液。並比較配方液與供養膠體,對於促進角質幹細胞增生的貢獻,來挑選最佳的配方液與最佳的供養膠體為何。並以cytokeratin-10與TUNEL染色法,判斷角質細胞有沒有產生我們不想要的分化與凋亡。培養的結果顯示,角質幹細胞不利於在過滿盤的情況下增生,並且產生分化與凋亡。我們發現在繼代培養的實驗中,對於促進角質細胞增生及抑制角質細胞分化凋亡的功能來說,供養膠體的效果比配方液來的佳。角質幹細胞與最佳供養膠體共同培養於67%配方液中,可以維持角質幹細胞繼代培養的存活性與增生能力,並可以防止細胞分化與凋亡。藉著供養膠體與配方液的組合,我們提供了一個經濟而有效的方法,經由細胞間的即時溝通,不需要昂貴的添加物,即可大量的生產品質優良的角質幹細胞。另ㄧ方面,我們以改變培養液中鈣離子濃度的方式,調控角質幹細胞的增生與分化能力。將角質細胞培養於高、中、低鈣離子濃度之培養液中,分別為DMEM(1.2mM)、DK11(0.4mM)及K(0.03mM) 。測定角質細胞的MTT活性、增生能力及細胞群落形成的大小與形成效率。以定量PCR分析Caspase-14的表現量,判斷角質細胞分化的程度,並和增生能力作關聯性的分析。結果發現高鈣離子濃度會抑制角質細胞的增生、使細胞的存活性與群落形成效率降低。Caspase-14的表現增加,證明了較高的鈣離子濃度有促進分化的效果。整體而言,培養液中鈣離子的適度增加,提高了角質化的速度,角質的形成對於皮膚的保護功能有加分的作用。最後,我們將纖維母細胞接種於預先製備好的三維膠原蛋白支架中,培養成真皮等價物之後,以組合的配方液幫助角質幹細胞接種於其表面,再以增生培養方式建構表皮基底層。在不同的培養階段探討EGF的添加,對於表皮形成的影響。分析細胞存活性、基因表現、組織型態及免疫染色之間的關連性,綜合評估細胞-支架-訊息因子之間交互調控的作用機制。於氣-液介面下培養的結果發現,持續性的添加10ng/ml的EGF,會造成異常的分化結果,包括:較薄的表皮分化層、不佳的細胞-基質介面及不良的組織形態等等。但是適時的添加EGF可以得到良好的組織型態,這是由於表皮角質細胞與真皮纖維母細胞間,有即時溝通的結果,經由生長因子的paracrine與autocrine,或是回饋機制的調控,維持組織的正常狀態。實驗的結果說明,EGF可以參考細胞特定基因的表現狀況(例如:KGF與TGF-beta1),作適度的添加。 | zh_TW |
dc.description.abstract | Abstract
Fibroblasts produce a spectrum of necessary growth factors essential for growth and proliferation of a variety of cell types. First aim of this study was prepared the feeder gel with optimum fibroblast density and optimum conditioned medium that promoted keratinocyte proliferation without further differentiation for skin equivalent tissue engineering. The optimum cell density in collagen feeder gel for optimum selected medium preparation will be determined by checking the level of keratinocyte growth factor (KGF) and granulocyte/macrophage colony-stimulating factor (GM-CSF) in conventional medium. The results showed that the cell density of 1x105 cells/gel in the feeder gel is better to produce optimum selected medium. The conditioned medium is prepared by mixing the optimum selected medium and MCDB 153 medium together in different ratios for keratinocyte growth. The keratinocyte viability will be measured by MTT assay to determine the optimum conditioned medium. From the study, 67% conditioned medium was supposed the better medium for the keratinocyte proliferation. In this experiment, the optimum cell density in feeder gel to co-culture with keratinocyte is also determined as 1x105 cells/gel. Cytokeratin-10 and TUNEL stain will be used to check the cell differentiation and apoptosis, respectively. The results suggest that keratinocyte should not be cultured in post-confluent condition due to toward undesired apoptosis and differentiation. The result of cell viability from passages to passages shows that the optimum feeder gel plays more important role to the keratinocyte proliferation than that of optimum conditioned medium. Keratinocytes cultured with optimum feeder gel in 67% conditioned medium could effectively promote proliferation, inhibit apoptosis and prevent from differentiation. The combination of conditioned media and feeder gel to culture keratinocyte without external supplements can provide an inexpensive way for keratinocyte proliferation and construct an environment for real-time communication between the two cells. The results conclude that keratinocyte cultivation in feeder gel with modified medium should be feasible in the production of high quality keratinocyte for skin equivalents preparation. The second approach of preparing skin equivalents is regulation of proliferated and differentiated capacity. We investigated Ca2+ effects on the proliferation and differentiation using the primary keratinocytes model. Keratinocytes were incubated in DMEM (containing 1.2 mM Ca2+ concentration) or DK11 medium (containing 0.4 mM Ca2+ concentration) or K medium (containing 0.03 mM Ca2+ concentration). Cell viability was assessed with the MTT assay. Crystal violet assay was evaluated the proliferation rate and colony formation size of keratinocyte. Real-time PCR used to determine the terminal differentiated keratinocyte which expressed Caspase-14. Proliferation assays and real–time PCR were correlated with either proliferation or differentiation in cultured human skin epidermal keratinocytes. High Ca2+ concentration was inhibited the cell viability and proliferation rate of keratinocyte. Ca2+ also increased caspases-14 expression, and inhibited cell viability, and cell colony forming efficiency. These results are consistent with Ca2+ induction of the keratinocyte differentiation. Thus, the overall Ca2+ actions connote protective functions for the epidermis that appear to include the triggering or acceleration of the differentiation. At last, we designed a novel culture system included a self-designed 3-D collagen scaffold with different pore size and specific culture media for different culture stages. This skin equivalent culture model provides a new investigating system to study the role of extracellular matrix and growth factors including epidermal growth factor (EGF), keratinocyte growth factor (KGF), transforming growth factor beta 1 (TGF-beta1), in the cell-cell and cell-matrix interactions. Keratinocytes were seeded onto the dermal equivalent and incubated under submerged condition for 5 days then proceeding to air-liquid interface cultured either with or without EGF addition. In this study, EGF has a positive effect on the keratinocyte migration and proliferation in the submerged stage. However, when 10ng/ml of EGF was continual added in the air-lifted stage, a less organized and thin differentiated keratinocyte layers were found. Continual 10ng/ml of EGF addition in the air-lifted stage resulted in uneven cell-matrix interface, and disorganization of the suprabasal layers. On the contrary, in the air-lifted stage without excess EGF, the epithelium cells will stratify, differentiate, and form an epidermis completed with basal, spinous, granular, and cornified layers. The results showed that time scale modulation of EGF on keratinocyte cell behavior depend on the expression of paracrine or autocrine growth factors (e.g. KGF and TGF-beta1). | en |
dc.description.provenance | Made available in DSpace on 2021-06-13T06:36:32Z (GMT). No. of bitstreams: 1 ntu-94-D90548001-1.pdf: 7906542 bytes, checksum: 200d7befcbc13d0362adc44153d7ce90 (MD5) Previous issue date: 2005 | en |
dc.description.tableofcontents | 目錄
目錄………………………………………………………………………I 圖索引…………………………………………………………………IV 表索引…………………………………………………………………VI 摘要……………………………………………………………………VII Abstract……………………………………………………………VIII Abbreviations………………………………………………………X 第一章 緒論……………………………………………………………………1 1-1 前言……………………………………………………………1 1-2 皮膚的生理、燒燙傷與創傷修復……………………………3 1-2-1 皮膚的組成與功能……………………………………3 1-2-2 燒燙傷…………………………………………………7 1-2-3 皮膚創傷的修復過程…………………………………9 1-3 組織工程的定義與基本概念……………………………15 1-4 組織工程的三要素-細胞、支架、訊息………………16 1-4-1 細胞……………………………………………………16 1-4-2 支架……………………………………………………17 1-4-3 訊息因子………………………………………………18 1-5 人工皮膚及皮膚組織工程的發展………………………19 1-5-1 人工表皮………………………………………………21 1-5-2 人工真皮………………………………………………21 1-5-3 人工複合皮膚…………………………………………22 1-5-4 組織工程皮膚…………………………………………23 1-6 研究方向…………………………………………………24 第二章 理論基礎與實驗設計…………………………………25 2-1 細胞貼附蛋白與細胞外基質……………………………26 2-1-1 細胞貼附蛋白……………………………………………26 2-1-2 細胞外基質………………………………………………29 2-2 細胞生長的調節……………………………………………36 2-2-1 細胞週期…………………………………………………36 2-2-2 角質幹細胞標定…………………………………………38 2-2-3 角質幹細胞的分化與角質化過程………………………41 2-2-4 細胞貼附蛋白與細胞外基質對角質幹細胞增生和分化的調節...42 2-2-5 生長因子對角質幹細胞增生和分化的調節……………………44 2-3 支架製備的考量…………………………………………49 2-3-1 支架需要的生物特性…………………………………49 2-3-2 膠原蛋白的生物特性及其可加工能力………………50 2-3-3 膠原蛋白的萃取原理……………………………53 2-3-4 適合角質細胞與纖維母細胞共同培養的支架結構…55 2-4 細胞培養環境與培養液…………………………………57 2-5 實驗評估原理……………………………………………60 2-5-1 蛋白質膠體電泳法(SDS-PAGE)………………………60 2-5-2 表面形態評估…………………………………………60 2-5-3 支架孔隙率評估………………………………………61 2-5-4 支架交聯度評估………………………………………61 2-5-5 細胞存活性評…………………………………………61 2-5-6 基因表達評估 即時-聚合酶連鎖反應(Real-Time PCR)……62 2-5-7 細胞凋亡評估……………………………………………63 2-6 實驗設計……………………………………………………64 2-6-1支架製備的設計…………………………………………65 2-6-2 細胞擴增模型……………………………………………65 2-6-3 角質幹細胞的誘導分化…………………………………66 2-6-4 細胞接種方式的選擇……………………………………66 2-6-5 細胞接種培養(explant culture)與分化調控…………66 第三章 實驗方法…………………………………………………68 3-1 實驗儀器………………………………………………………68 3-2實驗藥品………………………………………………………69 3-3 實驗流程與方法……………………………………………70 3-3-1 第一型膠原蛋白萃取……………………………………72 3-3-2蛋白膠體電泳分析(SDS-PAGE)……………………………73 3-3-3 第一型膠原蛋白支架製備……………………………74 3-3-4 支架交聯程度分析………………………………………75 3-3-5 掃描式電子顯微鏡分析………………………………75 3-3-6 降解速率測試……………………………………………76 3-3-7 支架滅菌方式……………………………………………76 3-4細胞擴增培養…………………………………………………77 3-4-1角質細胞分離及培養………………………………………78 3-4-2 纖維母細胞分離及培養…………………………………78 3-4-3 改良擴增培養角質細胞模型之最佳化…………………80 3-4-3-1 纖維母細胞之Mitomycin-C treatment…………80 3-4-3-2 製備膠原蛋白供養膠體(collagen feeder gel)……80 3-4-3-3 配方液(conditioned medium)的製備………………81 3-4-3-4 收集液(collected medium)的KGF 和 GM-CSF測量: 決定最佳收集液(optimum collected medium)………………82 3-4-3-5 配方液的製備……………………………………83 3-4-3-6 以配方液(conditioned medium)與供養膠體(feeder gel)作角質細胞增生測試:決定 ”最佳配方液” 與 ”最佳供養膠體”……………………………………………………………………83 3-4-3-7 測定繼代角質細胞之存活性:評估供養膠體和配方液的重要性...............................................84 3-5誘導角質幹細胞分化………………………………………85 3-5-1選擇同時可以促進增生與分化之培養液(medium)……85 3-5-2 培養液測試方式………………………………………85 3-5-3 細胞群落形成(Cell Colony Formation)………………85 3-5-4 細胞增生評估……………………………………………86 3-5-5 及時聚合酶連鎖反應(real-time PCR)………………86 3-6 細胞接種方式……………………………………………88 3-7 皮膚等價物培養模型……………………………………89 3-8 免疫化學染色分析………………………………………91 3-9 細胞凋亡分析……………………………………………92 3-10 資料統計分析……………………92 第四章 結果…………………………………………………93 4-1 支架評估………………………………………………93 4-2 角質細胞擴增培養結果與最佳化…………………94 4-3 誘導細胞的分化………………………………………99 4-4 細胞接種與體外皮膚等價物製備…………………101 第五章 討論………………………………………………132 第六章 結論………………………………………………140 第七章 未來展望…………………………………………141 第八章 參考文獻…………………………………………142 | |
dc.language.iso | zh-TW | |
dc.title | 體外製備全層皮膚等價物 | zh_TW |
dc.title | In-vitro Preparation of Full Thickness Skin Equivalent | en |
dc.type | Thesis | |
dc.date.schoolyear | 94-1 | |
dc.description.degree | 博士 | |
dc.contributor.oralexamcommittee | 陳天牧,楊禎明,孫瑞昇,郭宗甫,陳克紹,林睿哲,姚俊旭 | |
dc.subject.keyword | 配方液,供養膠體,膠原蛋白,角質細胞,纖維母細胞,皮膚等價物,生長因子, | zh_TW |
dc.subject.keyword | conditioned medium,feeder gel,collagen,keratinocyte,fibroblast,skin equivalent,growth factors, | en |
dc.relation.page | 153 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2005-12-14 | |
dc.contributor.author-college | 工學院 | zh_TW |
dc.contributor.author-dept | 醫學工程學研究所 | zh_TW |
顯示於系所單位: | 醫學工程學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-94-1.pdf 目前未授權公開取用 | 7.72 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。